Prezzo di chiusura
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
7,69 CNY | -1,03% |
|
-1,54% | -20,15% |
Attività
Vendite per attività
CNY in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Anti-infective Drugs
22,2
%
| 173 | 20,9 % | 177 | 22,2 % | +2,23% |
Urinary System Drugs
20,7
%
| 129 | 15,5 % | 165 | 20,7 % | +28,39% |
Other Medicines
17,0
%
| 119 | 14,4 % | 136 | 17,0 % | +13,61% |
Pediatric Use
8,4
%
| 70 | 8,4 % | 67 | 8,4 % | -3,42% |
Anti-allergy
8,3
%
| 166 | 20,1 % | 66 | 8,3 % | -60,22% |
Respiratory Medicine
7,2
%
| 39 | 4,7 % | 58 | 7,2 % | +47,77% |
Pharmaceutical Raw Materials and Intermediates
7,1
%
| 46 | 5,6 % | 57 | 7,1 % | +22,82% |
Service
3,3
%
| 34 | 4,1 % | 27 | 3,3 % | -20,84% |
Kidney Medicine
3,3
%
| 37 | 4,5 % | 26 | 3,3 % | -29,20% |
Health Food
1,6
%
| 11 | 1,3 % | 13 | 1,6 % | +16,91% |
Other Business
0,9
%
| 4 | 0,5 % | 7 | 0,9 % | +65,81% |
Commercial
0,1
%
| 0 | 0,1 % | 1 | 0,1 % | +71,18% |
Vendite per regione
CNY in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
China
100,0
%
| 807 | 97,3 % | 799 | 100,0 % | -0,93% |
Hong Kong
0,0
%
| 22 | 2,7 % | 0 | 0,0 % | -99,09% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Qun Zhao
CEO | Chief Executive Officer | 53 | 01/03/05 |
Yan Jie He
DFI | Director of Finance/CFO | 42 | 01/12/10 |
Hai Rong Zhong
BRD | Director/Board Member | 65 | 17/03/15 |
Jun Xian Yu
BRD | Director/Board Member | 57 | 01/03/05 |
Xu Hong Zhang
BRD | Director/Board Member | 53 | 01/03/05 |
Yuan Yuan Xue
IRC | Investor Relations Contact | - | - |
Ying Min Yu
PRN | Corporate Officer/Principal | 61 | 07/07/16 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Qun Zhao
CEO | Chief Executive Officer | 53 | 01/03/05 |
Xu Hong Zhang
BRD | Director/Board Member | 53 | 01/03/05 |
Jun Xian Yu
BRD | Director/Board Member | 57 | 01/03/05 |
Hai Rong Zhong
BRD | Director/Board Member | 65 | 17/03/15 |
Hao Gao
BRD | Director/Board Member | 54 | 11/02/20 |
Le Qun Huang
CHM | Chairman | 69 | 01/02/20 |
Tao Ju
BRD | Director/Board Member | 38 | 11/02/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 241 618 563 | 182 672 525 ( 75,60 %) | 0 | 75,60 % |
Coordinate società
Shanxi C&Y Pharmaceutical Group Co., Ltd.
1378, Heng'an Street Economic & Technological Dev Zone
037010, Datong
+
http://www.cy-pharm.com![Indirizzo ShanXi C&Y Pharmaceutical Group Co.,LTD.(300254)](https://cdn.zonebourse.com/static/address/11367302.png)
Settore
Vendite per attività
Vendite per regione
Variaz. 1 gen. | Capi. | |
---|---|---|
-20,15% | 256 Mln | |
+61,53% | 848 Mrd | |
+38,95% | 627 Mrd | |
-3,66% | 363 Mrd | |
+15,06% | 318 Mrd | |
+9,18% | 299 Mrd | |
+5,89% | 234 Mrd | |
+16,53% | 225 Mrd | |
+15,67% | 179 Mrd | |
+2,47% | 167 Mrd |
- Borsa valori
- Azioni
- Azione 300254
- Società ShanXi C&Y Pharmaceutical Group Co.,LTD.